An in-depth investigation report on Ranbaxy Laboratories in India was published in Fortune magazine, titled 'Dirty Medicine,' and written by Katherine Eban. The report investigated the long-term criminal fraud conducted by the company (Eban, 2013). Ranbaxy Laboratories, located in Gurgaon, India is the primary foreign manufacturers of generics selling drugs all over the United States. The company allegedly committed a massive fraud while manufacturing, testing, marketing, and selling its generic drug, all across the globe. According to the report, Ranbaxy pleaded guilty on May 13, 2013, to "seven federal criminal counts of selling adulterated drugs with intent to defraud, ...